Blueshift Asset Management LLC Has $1.02 Million Stock Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

Blueshift Asset Management LLC increased its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 48.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 26,200 shares of the company's stock after purchasing an additional 8,576 shares during the quarter. Blueshift Asset Management LLC's holdings in Bath & Body Works were worth $1,016,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. FMR LLC grew its position in shares of Bath & Body Works by 17,496.5% during the 3rd quarter. FMR LLC now owns 2,516,127 shares of the company's stock worth $80,315,000 after buying an additional 2,501,828 shares during the period. Erste Asset Management GmbH bought a new position in Bath & Body Works in the third quarter valued at approximately $50,483,000. Senvest Management LLC acquired a new stake in Bath & Body Works during the 3rd quarter worth $30,537,000. Principal Financial Group Inc. raised its position in shares of Bath & Body Works by 328.7% during the 3rd quarter. Principal Financial Group Inc. now owns 1,069,941 shares of the company's stock valued at $34,153,000 after acquiring an additional 820,379 shares during the last quarter. Finally, Verition Fund Management LLC lifted its stake in shares of Bath & Body Works by 111.8% in the 3rd quarter. Verition Fund Management LLC now owns 1,345,777 shares of the company's stock valued at $42,957,000 after purchasing an additional 710,333 shares during the period. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Stock Performance

Bath & Body Works stock traded up $2.19 during mid-day trading on Monday, reaching $32.47. The company's stock had a trading volume of 6,723,627 shares, compared to its average volume of 4,260,692. The business's 50 day simple moving average is $35.62 and its 200 day simple moving average is $34.01. The company has a market capitalization of $6.96 billion, a price-to-earnings ratio of 7.92, a price-to-earnings-growth ratio of 0.92 and a beta of 1.89. Bath & Body Works, Inc. has a 12 month low of $26.21 and a 12 month high of $52.99.

Remove Ads

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, beating the consensus estimate of $2.04 by $0.05. The company had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. As a group, sell-side analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works announced that its board has authorized a stock repurchase plan on Thursday, February 27th that allows the company to repurchase $500.00 million in outstanding shares. This repurchase authorization allows the company to purchase up to 6.4% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company's leadership believes its stock is undervalued.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 21st were paid a $0.20 dividend. The ex-dividend date was Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a yield of 2.46%. Bath & Body Works's dividend payout ratio (DPR) is 21.98%.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. Deutsche Bank Aktiengesellschaft lifted their price objective on Bath & Body Works from $51.00 to $52.00 and gave the stock a "buy" rating in a research note on Tuesday, November 26th. Citigroup raised shares of Bath & Body Works from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $40.00 to $48.00 in a research note on Friday, February 28th. Raymond James reaffirmed an "outperform" rating and issued a $46.00 target price (up previously from $42.00) on shares of Bath & Body Works in a research note on Tuesday, February 25th. Cowen reissued a "buy" rating on shares of Bath & Body Works in a research report on Thursday, February 27th. Finally, Robert W. Baird upped their price objective on shares of Bath & Body Works from $45.00 to $47.00 and gave the company an "outperform" rating in a research report on Friday, February 28th. Five equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $45.06.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.